|

NEO-811 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Neomorph, Inc1

Indications

  • Kidney Cancers1
  • VHL-Associated Renal Cell Carcinoma1
  • VHL-Associated Clear Cell Renal Cell Carcinoma1
  • ccRCC1
  • Clear Cell Renal Cell Carcinoma Metastatic1

Grand Rapids, Michigan1 trial

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NEO-811 Grand Rapids Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.